Related Experiment Video
Updated: Jul 24, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Observed consensus on research priorities for the hypertriglyceridemia patient registry
Steve Freedman1, Enrique de-Madaria2, Eric Bruckert3
1The Pancreas Center, Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, USA.
This study identified research priorities for triglyceride-induced acute pancreatitis (TG-IAP) using expert consensus. The findings aim to improve patient data collection and management for better outcomes.
Area of Science:
- Medical research
- Clinical epidemiology
- Health outcomes research
Background:
- Health research priority setting is crucial due to global health disparities.
- Real-world evidence generation is increasing, driven by pharmaceutical interests.
- Valuable research priorities are essential for guiding scientific inquiry.
Purpose of the Study:
- To identify critical knowledge gaps in triglyceride-induced acute pancreatitis (TG-IAP).
- To generate a list of potential research priorities for a Hypertriglyceridemia Patient Registry.
Main Methods:
- Employed the Jandhyala Method for expert opinion consensus.
- Gathered input from ten specialist clinicians in TG-IAP treatment across the US and EU.
Main Results:
- Ten participants reached consensus, generating 38 unique research items.
- These items informed research priorities for a hypertriglyceridemia patient registry.
- Demonstrated a novel application of the Jandhyala method for research question development and core dataset validation.
Conclusions:
- A harmonized framework for TG-IAP patient observation can be developed using the core dataset and research priorities.
- This framework will enhance disease knowledge, improve research quality by addressing data incompleteness, and enable new tool validation.
- Improved diagnosis, monitoring, disease severity detection, and patient management are expected, leading to better patient outcomes and quality of life.
More Related Videos
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Chronic Pancreatitis II: Collaborative Care
Assessment: